Exosome mimetics derived from bone marrow mesenchymal stem cells deliver doxorubicin to osteosarcoma <i>in vitro</i> and <i>in vivo</i>
Exosome mimetics derived from bone marrow mesenchymal stem cells deliver doxorubicin to osteosarcoma <i>in vitro</i> and <i>in vivo</i> is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Exosome mimetics derived from bone marrow mesenchymal stem cells deliver doxorubicin to osteosarcoma <i>in vitro</i> and <i>in vivo</i> have?
Exosome mimetics derived from bone marrow mesenchymal stem cells deliver doxorubicin to osteosarcoma <i>in vitro</i> and <i>in vivo</i> has 58 citations in the OpenAlex counts ScholarIQ stores.
When was Exosome mimetics derived from bone marrow mesenchymal stem cells deliver doxorubicin to osteosarcoma <i>in vitro</i> and <i>in vivo</i> published?
Exosome mimetics derived from bone marrow mesenchymal stem cells deliver doxorubicin to osteosarcoma <i>in vitro</i> and <i>in vivo</i> has 2022 year in the ScholarIQ index.
What is the open-access status of Exosome mimetics derived from bone marrow mesenchymal stem cells deliver doxorubicin to osteosarcoma <i>in vitro</i> and <i>in vivo</i>?
Exosome mimetics derived from bone marrow mesenchymal stem cells deliver doxorubicin to osteosarcoma <i>in vitro</i> and <i>in vivo</i> has gold oa status in the ScholarIQ index.
What is the DOI of Exosome mimetics derived from bone marrow mesenchymal stem cells deliver doxorubicin to osteosarcoma <i>in vitro</i> and <i>in vivo</i>?
The DOI for Exosome mimetics derived from bone marrow mesenchymal stem cells deliver doxorubicin to osteosarcoma <i>in vitro</i> and <i>in vivo</i> is on the source record.
What is the PMID of Exosome mimetics derived from bone marrow mesenchymal stem cells deliver doxorubicin to osteosarcoma <i>in vitro</i> and <i>in vivo</i>?
The PMID for Exosome mimetics derived from bone marrow mesenchymal stem cells deliver doxorubicin to osteosarcoma <i>in vitro</i> and <i>in vivo</i> is on the source record.
What is the OpenAlex record for Exosome mimetics derived from bone marrow mesenchymal stem cells deliver doxorubicin to osteosarcoma <i>in vitro</i> and <i>in vivo</i>?
The OpenAlex for Exosome mimetics derived from bone marrow mesenchymal stem cells deliver doxorubicin to osteosarcoma <i>in vitro</i> and <i>in vivo</i> is on the source record.